BOSTON--(BUSINESS WIRE)--DSG Inc., an industry leader in eClinical software and services to the life science industry, today announced that it will be releasing the newest version of their flagship ...
MALVERN, Pa.--(BUSINESS WIRE)--Human Genome Sciences (HGS: NASDAQ: HGSI) announced that BENLYSTA TM met the primary endpoint in BLISS-52, the first of two pivotal Phase 3 trials in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results